ImmVue Therapeutics is a biotechnology company.
ImmVue Therapeutics has raised $529K in total funding. The most recent round was Seed. The last funding was announced in March 2024.
ImmVue Therapeutics is headquartered in Toronto, Canada.
ImmVue Therapeutics is a biotechnology company.
ImmVue Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmVue Therapeutics — Funding & Investors." VCBacked, March 19, 2024, https://www.vcbacked.co/company/immvue-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). ImmVue Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/immvue-therapeutics
{{cite web |title=ImmVue Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/immvue-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated